Inaperisone
Alternative Names: HN 770; HSR 770; HY 770; Inaperisone hydrochloride; Riran; YM 170Latest Information Update: 22 Dec 1999
At a glance
- Originator Hokuriku Seiyaku
- Developer Hokuriku Seiyaku; Yamanouchi
- Class Propiophenones; Small molecules
- Mechanism of Action Neuromuscular blocking agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Muscle hypertonia; Urinary incontinence
Most Recent Events
- 22 Dec 1999 Discontinued-preregistration for Urinary incontinence in Japan (PO)
- 20 May 1998 Discontinued-preregistration for Hypertonia in Japan (PO)
- 02 Feb 1998 No-Development-Reported for Hypertonia in Japan (PO)